Antibiotic Sensitivity Test: Cefotaxime Breakpoint Detection (Microscopic Observation)
This test helps determine whether your bacteria are likely to be resistant to the antibiotic cefotaxime, which is used to treat certain infections. Results guide decisions about treatment options.
["Assists doctors in choosing the most effective antibiotic for your infection by identifying potential resistance patterns."]
Key facts at a glance
- LOINC
- 101479-4
- Short code
- CEFOTAX
- Synonyms
- Cefotaxime Bld Pos MIC.VOC det
- Category
- chemistry
- Sample
- whole-blood
- Container
- Positive blood culture bottle (aerobic and/or anaerobic) inoculated with whole blood; standard BacT/ALERT, BACTEC, or equivalent blood culture system bottles
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- mic-voc-detection
- CPT
- 87186
- SNOMED
- 363525000
- Specimen volume
- 8-10 mL of whole blood per blood culture bottle (adult); minimum 1-3 mL for pediatric bottles
- Stability
- Blood culture bottles must be incubated promptly upon collection and continuously monitored. Once flagged positive, perform susceptibility testing as soon as possible; do not exceed 24 hours after positivity alert.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 12–48 hours
- Order
- routine
What This Test Measures
This test evaluates the bacteria’s response to cefotaxime by observing growth inhibition under a microscope. A positive result (no visible growth) suggests the bacteria are sensitive to the drug, while a negative result (growth visible) may indicate resistance. This is a qualitative screening, not a precise measurement of antibiotic concentration.
Specimen and Preparation
A sample of your blood is taken and mixed with bacteria from your infection. The mixture is then exposed to cefotaxime and observed for bacterial growth. No special preparation is needed beyond standard blood draw procedures.
How the Test Works
The test uses a qualitative method to detect whether bacteria grow in the presence of cefotaxime. If bacteria survive (visible growth), they may be resistant. If they do not grow (no visible growth), they are likely sensitive. This is a visual assessment, not a numerical measurement.
When You Might Need This Test
This test is typically ordered when your doctor suspects bacterial infections that may require cefotaxime treatment, such as certain types of pneumonia, urinary tract infections, or meningitis. It helps ensure the antibiotic chosen will be effective against your specific infection.
Reference range
Interpretive categories per CLSI breakpoints: Susceptible (S) ≤ 1 µg/mL, Intermediate (I) 2 µg/mL, Resistant (R) ≥ 4 µg/mL for Enterobacterales; refer to current CLSI M100 or EUCAST guidelines for specific organism breakpointsN/A
No fasting required. Specimen should be collected prior to initiation of antimicrobial therapy whenever possible. If patient is already on antibiotics, note medication and timing on requisition.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
Cefotaxime MIC Screening (Qualitative)
Frequently asked questions
Why might my doctor order this test?
How long will I need to wait for results?
What if the test shows resistance to cefotaxime?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy